The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases - Al-Shamsi - Journal of Gastrointestinal
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
CA 19-9 Antigen - an overview | ScienceDirect Topics
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers
Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
CA 19-9: handle with care
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text
CA 19-9 tumor marker | pancreatic cancer diagnosis | tumor marker (Everything you need to know) - YouTube
![PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a96fc01f495907ea18214fdc7db7ffd9b210d72c/2-TableI-1.png "PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar")
PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
![PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/75c7a5a10a62339b88fe5157b0ecc21dd7bfacd8/2-Table3-1.png "PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar")
PDF] Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. | Semantic Scholar
Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma | Scientific Reports
Tumor marker CA 19.9 and CEA studies, with TNM staging at presentation | Download Scientific Diagram
58 Ca19 9 Images, Stock Photos & Vectors | Shutterstock
